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JunD, a transcription factor of the AP-1 family, pro-
tects cells against oxidative stress. Here, we show
that junD/ mice exhibit features of premature aging
and shortened life span. They also display persistent
hypoglycemia due to enhanced insulin secretion.
Consequently, the insulin/IGF-1 signaling pathways
are constitutively stimulated, leading to inactivation
of FoxO1, a positive regulator of longevity. Hyperinsu-
linemia most likely results from enhanced pancreatic
islet vascularization owing to chronic oxidative stress.
Indeed, accumulation of free radicals in b cells en-
hances VEGF-A transcription, which in turn increases
pancreatic angiogenesis and insulin secretion. Ac-
cordingly, long-term treatment with an antioxidant
rescues the phenotype of junD/ mice. Indeed, die-
tary antioxidant supplementation was protective
against pancreatic angiogenesis, hyperinsulinemia,
and subsequent activation of insulin signaling cas-
cades in peripheral tissues. Taken together, these
data establish a pivotal role for oxidative stress in sys-
temic regulation of insulin and define a key role for the
JunD protein in longevity.
INTRODUCTION
The accumulation of reactive oxygen species (ROS) beyond the
homeostatic threshold is linked to the appearance of age-related
diseases, including cancer (for review, see Balaban et al., 2005;
Frisard and Ravussin, 2006). Nearly 50 years ago, Harman pro-
posed the ‘‘free radical theory of aging,’’ which suggests that
aging and associated degenerative diseases result from the
deleterious effects of free radicals on numerous cellular compo-
nents including lipids, proteins, and nucleic acids (Harman,
1956). Today, although aerobic metabolism and the correspond-
ing generation of ROS remain the most widely accepted cause
of aging, substantial unknowns persist. Interestingly, the insu-
lin/IGF-1 pathways, which have been defined as key regulators
of longevity in various species, also modulate resistance againstCROS (reviewed in Kenyon, 2005; Warner, 2005; Murakami, 2006;
Giannakou and Partridge, 2007). Binding of insulin/insulin-like
signaling molecules to their tyrosine kinase receptors triggers
the recruitment and subsequent activation of phosphatidy-
linositol 3-kinase (PI3K), which in turn activates several serine/
threonine kinases including Akt (for review, see Manning and
Cantley, 2007). The FoxO family of transcription factors is a direct
substrate of Akt in response to insulin (for reviews, see Arden,
2007; Carter and Brunet, 2007; Huang and Tindall, 2007). Akt
phosphorylates conserved residues in FoxO proteins, triggers
their export to the cytoplasm, and inactivates them. In
C. elegans, the extended life span of insulin-like signaling mu-
tants is lost when the worm FoxO ortholog DAF-16 is inactivated
(Lin et al., 1997; Ogg et al., 1997). FoxO or DAF-16 induces a gene-
tic program that promotes both resistance to oxidative stress
and longevity (for reviews, see Baumeister et al., 2006; van der
Horst and Burgering, 2007). Taken together, these data eluci-
date how insulin/IGF-1 signaling modulates ROS levels and life
span through the conserved PI3K/Akt/FoxO signal transduction
pathway.
The AP-1 transcription factor plays a key role in regulating
cell growth and environmental stress responses. AP-1 is com-
posed of homo- or heterodimers between Jun (c-Jun, JunB, and
JunD) and Fos or ATF family members (for review, see Mechta-
Grigoriou et al., 2001). Recently, we discovered a new function
of JunD in controlling oxidative stress and the angiogenic switch
(Gerald et al., 2004; Pouyssegur and Mechta-Grigoriou, 2006).
JunD protects cells against oxidative stress by regulating genes
involved in antioxidant defense and H2O2 production. Using
junD-deficient fibroblasts, we uncovered a molecular mechanism
linking oxidative stress to angiogenesis. Accumulation of H2O2
reduces the activity of HIF-prolyl hydroxylases (PHDs), which in
turn signal hypoxia-inducible factor (HIF) a subunits for degrada-
tion. Subsequently, HIF-a proteins accumulate and enhance the
transcription of VEGF-A (vascular endothelial growth factor A),
a potent proangiogenic factor. Thus, our previous study deter-
mined that JunD protects cells from oxidative stress and exerts
an antiangiogenic effect.
Angiogenesis has recently been shown to play an essential
part in modulating insulin production. Crosstalk between endo-
thelial and endocrine cells is crucial for endocrine gland function
since endocrine cells sense molecules in the bloodstream andell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc. 113
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cular development by secreting VEGF-A (Inoue et al., 2002; Lam-
mert et al., 2003b; Brissova et al., 2006). Endothelial cells signal
back to endocrine cells by producing extracellular matrix (ECM)
and promoting b cell function (Duvillie et al., 2006; Nikolova et al.,
2006). Mice that are genetically depleted of islet capillaries ex-
hibit lower levels of insulin expression and secretion (Brissova
et al., 2006; Nikolova et al., 2006). These observations support
previous studies showing that a proper vasculature is necessary
for the initial induction of insulin synthesis during embryogenesis
(Lammert et al., 2001, 2003a; Yoshitomi and Zaret, 2004).
Consistent with the notion that resistance to oxidative stress
is highly coupled to life-span extension, we show here that inac-
tivation of junD decreases longevity in mice. This effect is medi-
ated at least in part by an increase in pancreatic angiogenesis
and subsequent enhanced insulin production. Stimulation of the
insulin-dependent signaling pathways inactivates FoxO1, which
conceivably accelerates aging. Interestingly, the phenotype
that results from constitutive oxidative stress due to junD deletion
is rescued to a large extent by long-term antioxidant treatment.
Our study thus identifies an angiogenic mechanism by which
oxidative stress can modulate insulin/IGF-1 signaling and,
in turn, life span.
RESULTS
Inactivation of junD Decreases Life Span in Mice
We recently demonstrated that JunD protects cells against
oxidative stress, thereby reducing tumor angiogenesis (Gerald
et al., 2004). To further investigate the role of JunD in normal phys-
iology, we monitored a cohort of junD-deficient and wild-type
(WT) mice over their entire life span. At birth, junD/ mice were
indistinguishable from their WT littermates. However, at 2 months
of age, they exhibited growth retardation, as evidenced by
reduced body weight. Indeed, while the weight of WT animals
increased constantly, the weight of mutants stopped increasing
(Figure 1A). In contrast, the body length of junD-deficient animals
remained normal and comparable to controls (see Figure S1A
available online). Furthermore, when fed ad libitum on a standard
diet (5% fat) and maintained in regular housing until natural death,
the mutant mice exhibited a decrease in mean (17%) and maxi-
mum (14%) life span relative to WT littermates (p = 0.0005) (Fig-
ure 1B). No obvious difference was observed between heterozy-
gous and WT mice (data not shown). Long-term follow-up of
junD-deficient mice revealed a striking premature-aging pheno-
type. junD-deficient mice had a normal appearance until the
age of 6 months, when we first noted cataracts, slight hair
loss, and graying. As junD/ animals aged, mono- or bilateral
cataracts were frequently observed, and varying degrees of ca-
chexia, alopecia (loss of body hair), and lordokyphosis (abnormal
curvature of the spine) became evident (Figure 1C). Finally, post-
mortem examination revealed that the prematurely aging junD/
mice developed various types of neoplasia, with the most fre-
quent cause of death being high-grade diffuse lymphomas (aver-
age incidence 23%) (Figure 1D). Since lymphomas were also
detected at a similar frequency in old WT mice (data not shown),
they were considered as a feature of premature aging. These re-
sults indicate that junD inactivation in mice is associated with re-
duced life span and premature onset of aging-related syndromes.114 Cell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc.junD/ Mice Suffer from Persistent Hyperinsulinemia
Since metabolism may play an important role in controlling aging,
we explored several blood parameters in junD/ mice and com-
pared them to WT animals. We repeatedly observed that mice de-
fective in junDexpression had reduced blood glucose (Figure 2A).
In the fed state, junD/ animals had 23% lower blood glucose
levels than control animals (p < 0.005) (Figure 2A, left panel). Sim-
ilarly, in the fasted state, even though blood glucose levels de-
clined in both control and mutant mice, glucose values remained
20% lower in junD-deficient animals compared to WT littermates
(p < 0.01) (Figure 2A, right panel). junD/ mice suffered from
chronic hypoglycemia immediately after the weaning age, and
no sex-dependent differences were observed (Figure 2B). Ability
to handle a glucose load was assessed by carrying out an intra-
peritoneal glucose tolerance test (i.p.GTT) at 6 months of age
(Figure 2C). Although blood glucose levels remained lower in
junD/ mice compared to control animals, no significant differ-
ence was observed in the i.p.GTT response between WT and
junD-deficient mice, indicating that the junD/ mice did not
suffer from glucose intolerance or insulin resistance. We next
measured food and water intake but did not detect significant dif-
ferences between the two genotypes (Figure S1B). Since hypo-
glycemia and reduced body mass despite normal food intake
are phenotypes shared by long-lived mice with reduced secre-
tion of IGF-1 (Bartke and Brown-Borg, 2004), we next investigated
the IGF-1 levels. Serum IGF-1 levels were comparable in junD/
and WT mice (Figure 2D). Moreover, normal body length in junD-
deficient mice excluded a potential role for pituitary or growth
hormone receptor function.
As the ratio of insulin to glucagon is critical in maintaining
euglycemia, we next determined the serum levels of these hor-
mones in WT and junD/ mice (Figure 2E). Interestingly, blood
insulin levels in the mutant mice were higher than in controls.
In contrast, glucagon levels remained comparable between the
two genotypes. Consequently, the ratio of insulin to glucagon
was inappropriately high considering the mutants’ severe hypo-
glycemia (Figure 2E). To further explore the link between JunD
and metabolic abnormalities, we analyzed its expression pattern
in pancreas (Figure 2F). Interestingly, junD expression was
restricted to clustering islet cells and was not detected in the
exocrine tissue. Virtually all insulin-secreting b cells robustly ex-
pressed junD, while glucagon-positive a cells did not (Figure 2F).
Moreover, in accordance with plasma levels, the steady-state
insulin content was higher in junD/ islets than in WT pancreas.
Furthermore, the pancreatic glucagon content did not change
significantly between the two genotypes (Figure 2G). Hence,
enhanced pancreatic and plasma insulin levels in junD/ mice
account for their chronic hypoglycemia. Moreover, the pattern
of junD expression in the pancreas is consistent with a direct
effect on insulin production.
Increased Angiogenesis in junD/ Pancreatic Islets
Insulin secretion from pancreatic b cells is a tightly regulated
process that couples the uptake of glucose with ATP-sensitive
depolarization of the cell membrane to stimulate exocytosis
of insulin-containing granules (Yang and Berggren, 2006). We
measured ATP levels but did not observe any increase in ATP
levels in junD/ mice that could account for chronic release of
insulin (Figure S2A). Moreover, steady-state mRNA levels of
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Reactive Oxygen Species Control b Cell FunctionFigure 1. Senescence Features and Early Death of junD/ Mice
(A) Age-dependent changes in body weight of junD-deficient mice (junD/; gray line) and wild-type animals (WT; black line) (n = 10).
(B) Kaplan-Meyer survival curve of junD/ mice (gray line) and WT littermate controls (black line) (n = 35) (p = 0.0005, log-rank test).
(C) General appearance of 12-month-old WT and junD/ mice. junD/ mice suffer from cataracts (Cb), cachexia (Cd), alopecia (Ce, arrow), and lordokyphosis
(Cf, arrow) compared to WT animals (Ca and Cc).
(D) High-grade diffuse lymphomas in junD/ mice are characterized by lymphadenopathy (Da), splenomegaly (Db), and diffuse organization of the spleen (Dd),
with no visible follicles as detected in WT animals (Dc).
n represents the number of animals/condition/genotype. All values are presented as means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.005 by Student’s t test.Cell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc. 115
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Reactive Oxygen Species Control b Cell FunctionFigure 2. Metabolic Defects in junD-Deficient Mice
(A) Blood glucose levels in fed (left panel) and fasted (right panel) WT and junD/ mice (n = 12).
(B) Variation of blood glucose levels with age in junD/ mice (B) relative to WT counterparts ().
(C) Glucose tolerance tests after intraperitoneal administration of glucose load in 6-month-old animals of the indicated genotype (n = 9).
(D) Levels of plasma IGF-1 in fasted WT and junD/ mice (n = 7).116 Cell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc.
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transporter 2 [Slc2a2/Glut2], glucokinase [Gck], glutamate dehy-
drogenase [Glud1], and both subunits of the ATP-dependent K+
channel [Kcnj11/Kir6.1 and Abcc8/SUR1]) revealed no significant
changes (Figure S2B), suggesting that JunD regulates a distinct
process in b cells that contributes to the phenotype.
Interestingly, although junD-deficient mice displayed a macro-
scopically normal pancreas (Figure S2C), junD/ islets exhibited
an increase in vascularization as compared to those of WT ani-
mals (Figure 3A). Histological analysis of sections stained with
endothelial- and smooth muscle cell-specific antibodies showed
that the islets of junD/ mutants exhibited increased staining in
both cell types compared to controls (Figure 3A). By monitoring
the vascular density, we observed that the vascular content was
significantly increased in junD-deficient islets relative to controls
(Figure 3B). Since we recently demonstrated that junD inactiva-
tion enhances the expression of VEGF-A, a major proangiogenic
factor, by stabilizing its master regulator HIF-1a (Gerald et al.,
2004),weexploredwhetherHIF-1aaccumulates in junD/bcells
and stimulates the expression ofVEGF-A. Immunohistochemistry
using HIF-1a antibody revealed that HIF-1a protein levels were
higher in junD/ b cells relative to controls (Figure 3C). Further-
more, expression of VEGF-A was strongly increased in junD-
deficient b islets (Figure 3C). Consistent with previous studies
(Duvillie et al., 2006; Nikolova et al., 2006), we found that an in-
crease in the number of vascular cells in junD/ pancreas re-
sulted in the formation of capillaries enriched in basement mem-
brane proteins, such as fibronectin, next to the b cells (Figure 3C).
Recent studies have shown that endothelial cell signals pro-
mote insulin expression and secretion in adult islets (Brissova
et al., 2006; Nikolova et al., 2006). Consistently, both insulin 1
(Ins1) and insulin 2 (Ins2) mRNA levels were increased in junD/
pancreas compared to WT (Figure 3D). Moreover, since there is
a positive relationship between cytosolic Ca2+ and insulin release
(reviewed in Yang and Berggren, 2006), we examined changes in
cytosolic free Ca2+ levels in response to glucose from isolated WT
and junD/ islets. Under basal conditions (2.8 mM glucose),
resting Ca2+ concentration was significantly higher in junD-
deficient islets compared to controls (p < 0.005) (Figure 3E), sug-
gesting an enhanced constitutive secretory pathway, which could
contribute to basal hyperinsulinemia. In addition, free Ca2+ levels
reached higher levels after glucose stimulation (16 mM) in junD-
deficient islets relative to WT cells. Taken together, these data
show that junD-deficient pancreas accumulates the HIF-1a tran-
scription factor, inducing VEGF-A expression and b islet micro-
vasculature. Consequently, the angiogenic switch induced in
junD/ pancreas may play a critical role in insulin synthesis and
Ca2+-dependent insulin secretion.
Increased Angiogenesis in junD/ Pancreas
Results from Chronic Oxidative Stress
We and others have shown that the stability of the proangiogenic
factor HIF-1a is sensitive to redox status in well-oxygenated cellsC(for review, see Pouyssegur and Mechta-Grigoriou, 2006). Since
we previously established that JunD regulates genes involved in
antioxidant defense (Gerald et al., 2004), we evaluated ROS con-
tent in WT and junD/ pancreas using a cell-permeable mole-
cule that fluoresces when oxidized by peroxides (CM-H2DCFDA)
(Figure 4A). Interestingly, the ROS-specific signal exhibited
a 2-fold increase in junD/pancreas compared to WT. To further
assess the role of constitutive oxidative stress in persistent hy-
poglycemia, we subjected WT and junD/ mice to long-term
antioxidant treatment. N-acetylcysteine (NAC) was chosen
because it is well tolerated in animals and can be orally adminis-
tered over long periods of time. We first confirmed that long-term
administration of NAC decreased ROS content in junD/ pan-
creas (Figure 4B). In addition, NAC completely restored blood
glucose and plasma insulin content to normal levels in junD-
deficient mice (Figures 4C and 4D) and had no effect on glucagon
levels (Figure 4E). Finally, long-term NAC treatment significantly
reduced pancreatic angiogenesis in junD-deficient animals to
WT levels (Figures 4F and 4G). Thus, dietary supplementation
with antioxidant treatment turned out to be protective against
pancreatic angiogenesis, hyperinsulinemia, and hypoglycemia
in junD/ mice. In addition, NAC treatment restored the body
weight of junD/ mice to normal (Figure 4H). Moreover,
10-month-old NAC-treated junD/mice did not exhibit any signs
of premature aging, including cataracts, hair loss, or graying
(data not shown). This shows that antioxidant treatment also
rescued the premature-aging phenotype of junD/ mice,
although definitive proof concerning premature death may require
an additional treatment period of 15–20 months. In conclusion,
these data suggest that enhanced pancreatic angiogenesis
and subsequent increased insulin secretion and premature aging
result from chronic oxidative stress in junD-deficient mice,
a phenotype that is rescued to a large extent by long-term
antioxidant treatment.
Activation of Insulin-Dependent Pathways
in junD/ Mice
Since insulin signaling pathways are key regulators of longevity,
we next investigated to what extent the increased insulin levels in
junD/ mice affect intracellular signaling in peripheral insulin-
responsive tissues such as liver (Figure 5). We chose the liver be-
cause JunD is not expressed in hepatocytes (Thepot et al., 2000
and data not shown), enabling detection of circulating insulin in-
dependent of the constitutive oxidative stress caused by junD
deletion.
Western blot analysis showed a marked increase in tyrosine
phosphorylation of the insulin receptor (IR) in the liver of junD/
mice compared to controls (Figure 5A). As expected, insulin-
induced phosphorylation of Akt was also markedly increased in
junD-deficient tissues relative to WT tissues (Figure 5A). Further-
more, since FoxO1 has been identified as a major component of
insulin signaling, we investigated the level and degree of its phos-
phorylation in junD/ liver. Consistently, the levels of FoxO1(E) Levels of plasma insulin (left panel) and glucagon (middle panel) and ratio of insulin to glucagon (right panel) in fasted WT and junD/ mice (n = 13).
(F) Double immunohistochemistry of pancreas sections from adult mice detecting b-gal/JunD and insulin (upper panel) or glucagon (lower panel).
(G) Representative immunohistochemistry showing increased insulin and equivalent glucagon levels in junD/ pancreatic islets relative to WT.
Scale bars = 20 mm. n represents the number of animals/condition/genotype. All values are presented as means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.005 by
Student’s t test.ell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc. 117
Cell Metabolism
Reactive Oxygen Species Control b Cell Functionphosphorylation were increased in junD-deficient liver while the
total amount of FoxO1 protein decreased (Figure 5A), arguing
that it is constitutively inactivated and degraded in junD-deficient118 Cell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc.mice. Immunohistochemistry further confirmed that the levels of
phospho-FoxO1 were higher in junD-deficient hepatocytes com-
pared to controls (Figure 5B). As a consequence, total FoxO1Figure 3. Increased Angiogenesis in junD/ Pancreatic Islets
(A) Representative views of WT and junD/ pancreatic sections stained with specific antibodies as indicated. Arrows indicate typical vessels used for quanti-
fication.
(B) Vascular density (vessels/mm2) in WT and junD/ mice. Data shown are from three independent experiments (nR 10 fields per genotype).
(C) Representative views of WT and junD/ pancreatic sections stained with specific antibodies as indicated.
(D) Ins1 and Ins2 mRNA levels as measured by qPCR analysis in WT and junD/ mice (n = 6).
(E) Intracellular calcium measurements in isolated WT and junD/ islets at glucose concentrations of 2.8 mM and 16 mM (n = 3).
Scale bars = 20 mm. n represents the number of animals/condition/genotype. All values are presented as means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.005 by
Student’s t test.
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degradation resulting from phosphorylation. Finally, we moni-
tored insulin-dependent pathways in NAC-treated mice. Consis-
tent with its effect on blood glucose and insulin levels, NAC
reduced the phosphorylation rate of IR, Akt, and FoxO1 to WT
levels. Together, these data indicate that overproduction of insu-
lin in junD-deficient mice stimulates insulin-dependent cascades
in liver, which decreases FoxO1 activity, producing a phenotype
that is reversed by antioxidant treatment.
DISCUSSION
Longevity of eukaryotic organisms is modulated, at least in part,
by their ability to control metabolism and prevent oxidative dam-
age. In the present study, we have highlighted a key function of
persistent oxidative stress in pancreatic b cell function and me-
tabolism using junD-deficient mice. Accumulation of ROS in
pancreatic b cells increases pancreatic angiogenesis, which pre-
sumably stimulates insulin secretion. Consequently, peripheral
tissues exhibit constitutive activation of insulin signaling path-
ways and partial inactivation of the FoxO1 transcription factor,
which acts as a mediator of shortened life span. All these fea-
tures are alleviated by long-term antioxidant treatment, thereby
supporting the link between persistent oxidative stress and sys-
temic regulation of insulin (Figure 6).
Endocrine Regulation of Insulin by Oxidative Stress
Although it is now well established that oxidative stress can
cause aging through oxidative damages to various cell compo-
nents, one of the most prevalent systems that has emerged
from the search for longevity genes is the insulin/IGF-1 signaling
pathways. Since suppression of insulin/IGF-1 signaling extends
life span and delays age-dependent functional decline, these
hormones have been considered the most likely candidate effec-
tors of aging in diverse organisms. Long-lived mouse mutants
with impaired insulin/IGF-1 signaling also exhibit enhanced re-
sistance to oxidative stress (Holzenberger et al., 2003; Kurosu
et al., 2005; Yamamoto et al., 2005) (for reviews, see Bartke
and Brown-Borg, 2004; Murakami, 2006). In recent years, sev-
eral studies have substantiated the role of FoxO transcription
factors as downstream effectors of the insulin/IGF-1-PI3K-Akt
signaling pathway (reviewed in Huang and Tindall, 2007). Upon
reduction of insulin/IGF-1-dependent cascades and subsequent
inactivation of Akt, FoxO proteins are translocated into the
nuclei, leading to upregulation of oxidative-stress resistance
genes. Moreover, the p66shc redox enzyme that generates
ROS also modulates FoxO activity (Migliaccio et al., 1999;
Nemoto and Finkel, 2002). Longevity and resistance to oxidative
stress are thus associated with reduced insulin/IGF-1 signaling
and enhanced FoxO activity. The fact that junD/ mice suffer
from chronic oxidative stress, exhibit persistent hyperinsuline-
mia and FoxO1 inactivation, and age prematurely is consistent
with this hypothesis. These mice constitute an excellent model
for identifying new mechanisms linking accumulation of ROS to
long-term pathological consequences. Based on junD-deficient
mice, we propose that ROS and insulin signaling display recipro-
cal crosstalk. Although insulin/IGF-1 signaling pathways modu-
late intracellular ROS levels, we suggest here a regulatory feed-
back loop by which ROS regulate insulin levels. Indeed, we haveCidentified a proangiogenic mechanism by which oxidative stress
might control insulin synthesis and insulin-dependent cascades.
Although IGF-1 is clearly an important regulator of life span in
mammals (Holzenberger et al., 2003), the relationship between
insulin and aging is more complex (for review, see Russell and
Kahn, 2007). Some evidence suggests that decreased insulin
levels are correlated with longevity. For instance, caloric restric-
tion (CR) in mammals extends life span, and one proposed
mechanism by which this occurs is through reduced levels of
insulin (reviewed in Masoro, 2005). Indeed, CR cells show resis-
tance to oxidants and increased expression of stress-response
genes. Moreover, insulin or IGF-1 supplementation of CR serum
reduces resistance to ROS, consistent with the notion that
CR and insulin/IGF-1 pathways function in partially overlap-
ping mechanisms. Finally, fat-specific insulin receptor knockout
(FIRKO) mice have an increased life span, thereby demonstrat-
ing the beneficial effect of reduced insulin signaling in adipose
tissue on longevity (Bluher et al., 2003). In addition to demon-
strating that insulin signaling can regulate aging, the FIRKO
mouse establishes a non-cell-autonomous control of longevity.
Consistent with these observations, our data suggest that de-
spite normal IGF-1 levels, increased insulin levels modulate ag-
ing. Thus, in addition to oxidative damages, our results suggest
a ROS-mediated endocrine regulation of aging.
Increased b Islet Vasculature as a Result
of Chronic Oxidative Stress
b cells are ill equipped to dispose of ROS since the level of their
antioxidant enzymes is low (Welsh et al., 1995; Lenzen et al.,
1996). JunD regulates genes involved in antioxidant defense
and H2O2 metabolism (Gerald et al., 2004). It thus follows that
b cells from junD/ mice show high sensitivity to ROS. Indeed,
we detected clear accumulation of ROS in the pancreas of
junD/ mice. In contrast, basal ROS levels were not significantly
different between the livers of control and mutant mice, in agree-
ment with the fact that junD expression is not detected in hepato-
cytes (G.L. and B.B., unpublished data). We have recently shown
that constitutive oxidative stress enhances angiogenesis (Gerald
et al., 2004; Pouyssegur and Mechta-Grigoriou, 2006). We show
here that ROS accumulation in junD/ b cells increases b islet
angiogenesis. Pancreatic microvasculature has been shown to
play a pivotal role in endocrine islet development and function
(for reviews, see Cleaver and Melton, 2003; Zaret, 2006). Endo-
crine cells upregulate VEGF-A as soon as they start to secrete
hormones and signal to the adjacent endothelial cells to promote
the formation of a dense network of capillaries. Conversely, cap-
illary endothelial cells within islets produce a basement mem-
brane of ECM that signals back to pancreatic b cells and regu-
lates insulin levels (Duvillie et al., 2006; Nikolova et al., 2006).
Accordingly, specific removal of VEGF-A in b cells depletes islets
of capillaries, and the corresponding mice exhibit lower levels of
insulin expression and insulin secretory granules. Moreover,
ROS have recently been described as signaling molecules in glu-
cose-stimulated insulin secretion (Pi et al., 2007). We observed
a correlation between oxidative stress-mediated ectopic vascu-
larization and increased insulin expression and secretion in junD-
deficient pancreatic islets, consistent with these aforementioned
observations. Intriguingly, although glucose metabolism stimu-
lates glucagon secretion fromacells by a mechanism that mirrorsell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc. 119
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(A) Relative reactive oxygen species (ROS) levels in WT and junD/ pancreas as evaluated using the ROS-sensitive fluorescent dye CM-H2DCFDA (right panel). A
representative sample for three independent analyses is displayed (left panel).
(B) Relative ROS levels after long-term N-acetylcysteine (NAC) treatment in WT and junD/ mice (n = 3).
(C) Comparison of blood glucose levels in NAC-treated and untreated WT and junD/ mice (n = 7).
(D) Plasma insulin levels in NAC-treated and untreated WT and junD/ mice (n = 7).
(E) Plasma glucagon levels in NAC-treated and untreated WT and junD/ mice (n = 7).
(F) Representative views of NAC-treated WT and junD/ pancreatic sections stained with specific antibodies as indicated. Scale bars = 20 mm.
(G) Vascular density (vessels/mm2) in NAC-treated and untreated WT and junD/ mice (n = 3).120 Cell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc.
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secretion is not modified in junD/ mice. Since insulin has been
shown to inhibit glucagon secretion, we hypothesize that en-
hanced secretion of insulin in junD/mice antagonizes the poten-
tial prostimulatory effect of angiogenesis on glucagon secretion.
The angiogenic phenotype of junD/ b islets is completely
reversed by long-term antioxidant treatment: pancreatic and
plasma insulin levels are restored to normal levels after NAC ad-
ministration. Long-term administration of NAC to junD/ mice
confirms the cause-and-effect relationship between oxidative
stress, vascularization of pancreatic islets, and insulin secretion
and provides a new model for angiogenesis and longevity (Fig-
ure 6). Oxidative stress increases islet-secreted VEGF-A, which
in turn generates a permeable endothelium allowing an increased
amount of insulin to pass quickly into the bloodstream. Our data
extend previous observations and show that factors that modu-
late angiogenesis, such as ROS, are likely responsible for the in-
creased amount of insulin delivered into the systemic circulation.
JunD Protein: A Protective Function
in Aging and Insulin Signaling
The premature aging and death of junD/ mice are associated
with constitutive insulin secretion and signaling. Remarkably,Figure 5. Activation of Insulin Signaling
Pathways in Liver of junD/ Mice
(A) Western blot analysis of whole extracts from
livers isolated from WT and junD/ mice. Analysis
was performed using antibodies specific for the
insulin receptor (IR), Akt, FoxO1, and their corre-
sponding phosphorylated isoforms as indicated.
(B) Representative views of liver sections immuno-
stained with specific antibodies recognizing
FoxO1 and phospho-FoxO1. Scale bars = 30 mm.
(C) Western blot analysis using antibodies specific
for IR, Akt, FoxO1, and their corresponding phos-
phorylated isoforms in livers isolated from NAC-
treated WT and junD/ mice.
(D) Representative views of liver sections from
NAC-treated WT and junD/ mice immuno-
stained with FoxO1- and phospho-FoxO1-specific
antibodies. Scale bars = 30 mm.
the severity of the symptoms observed
in junD/ mice is amplified by the dele-
tion of one copy of the c-jun gene (G.L.
and F.M.-G., unpublished data), suggest-
ing that the different Jun proteins are
master regulators of aging and resistance
to oxidative stress in mammals. Since
ample genetic data have demonstrated
that insulin/IGF-1 pathways modulate
life span in various species, it will be of in-
terest to determine whether the function
of Jun in controlling life span is conserved
in lower organisms, such as Drosophila or
C. elegans.CIn this study, we show that JunD modulates insulin-dependent
pathways in mice through a ROS-dependent mechanism. Inter-
estingly, ROS have been shown to promote sustained Jun N-ter-
minal kinase (JNK) activation (Kamata et al., 2005). Moreover,
JNK controls life span and stress tolerance in Drosophila by
limiting insulin/IGF-1 signaling (Wang et al., 2003, 2005). In Dro-
sophila, JNK has been shown to act at two levels: cell autono-
mously, by antagonizing insulin/IGF-1 signaling and promoting
nuclear localization of Dfoxo, and systemically, by downregulat-
ing expression of Dilp2, a peptide that closely resembles insulin
(Wang et al., 2005). We show here that this mode of action is also
observed with JunD protein in mammals. Indeed, by decreasing
insulin levels and insulin signaling in peripheral tissues, JunD
influences life span in mice by cell-autonomous and non-cell-
autonomous mechanisms.
Pathological Consequences of Pancreatic
Oxidative Stress
Neonatal hyperinsulinism is a clinical syndrome of pancreatic
b cell dysfunction characterized by failure to suppress insulin
secretion despite hypoglycemia (for review, see Glaser, 2000).
The disease can be caused by recessive mutations in Kcnj11/
Kir6.1 or Abcc8/SUR1, by loss-of-function mutations in Gck, or(H) Body weight of NAC-treated WT and junD/ mice (n = 5).
n represents the number of animals/condition/genotype. All values are presented as means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.005 by Student’s t test.ell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc. 121
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et al., 2001; Stanley, 2004). However, in 45% of patients, the
basis of the pathology has not yet been elucidated. Since we
did not detect any variation in the expression of these genes in
junD/ mice, our current data suggest that persistent oxidative
stress in the pancreas promotes hyperinsulinism and may con-
tribute to the disease.
The metabolic state of hyperinsulinemic patients ranges from
recurrent hypoglycemia to insulin-requiring diabetes. Surpris-
ingly, despite prolonged ROS excess, aging junD-deficient
mice never develop insulin resistance, glucose intolerance, or di-
abetes. This indicates that although diabetes is typically accom-
panied by increased production of free radicals, chronic ROS
production is not sufficient in and of itself to cause b cell dysfunc-
tion and diabetes. Interestingly, insulin resistance in diabetes
can be associated with high levels of blood insulin, a mechanism
referred to as compensation. Indeed, b cells can attempt to com-
pensate for insulin resistance by increasing insulin secretion, and
insufficient compensation leads to the onset of glucose intoler-
ance. Our results suggest that ROS-mediated b islet vasculariza-
tion may participate in the first phases of this compensatory
mechanism and enhance insulin production. ROS-induced pan-
creatic angiogenesis may be one mechanism used by the organ-
ism to try to circumvent hyperglycemia. Future studies should
investigate whether increased pancreatic vascularization due
to junD inactivation may affect the severity of diabetes progres-
sion and obesity in models such as ob/obmice. If this hypothesis
is further confirmed, stimulating pancreatic angiogenesis may be
a useful therapeutic approach for promoting insulin delivery.
Proteins synthesized by pancreatic endothelial cells could be
valuable drug targets for preventing diabetic complications
and progressive b cell dysfunction.EXPERIMENTAL PROCEDURES
Mouse Strain
Due to the previously reported male sterility (Thepot et al., 2000), the junD-
deficient colony was maintained through the breeding of heterozygous ani-
mals, which produced progeny of all genotypes in the expected ratio, ruling122 Cell Metabolism 7, 113–124, February 2008 ª2008 Elsevier Inc.out any developmental defect. Genotyping was performed on DNA isolated
from the tails of mice by PCR as described previously (Thepot et al., 2000).
Mice were weighed and checked regularly until they died naturally. NAC (40 mM
in drinking water, Sigma) was initiated during embryogenesis (via treatment
of parent mice) and maintained throughout life. During all experiments, mice
were maintained on standard diet containing 5% fat (#1314, Altromin). The
Institut Curie ethical committee approved all experiments.
Analysis of Metabolic Parameters
Blood glucose values were determined from venous blood using an automated
glucose monitor (Accu-Chek, Roche). Plasma insulin and glucagon levels were
measured by the Luminex method (MENDO-75K, Linco), serum IGF-1 levels
using a radioimmunoassay kit (DSL2900, Diagnostic Systems Laboratories),
and ATP levels using a bioluminescence assay kit (1 699 695, Roche). Glucose
tolerance tests were carried out by intraperitoneally injecting overnight-fasted
mice with 2 g glucose/kg body weight. Venous blood was obtained from the
tail at 0, 15, 30, 60, and 120 min after injection.
Measurement of ROS Levels
ROS levels were determined in tissue extracts using ROS-sensitive fluorescent
dye (CM-H2DCFDA, Invitrogen). Mice were killed by cervical dislocation. Im-
mediately after dissection, pancreata were ground on a cell strainer. Medium
containing 7% FCS and 10 mM CM-H2DCFDA was poured through the
strainer. Cells were then collected and incubated in medium supplemented
with CM-H2DCFDA for 30 min at 37
C in 5% CO2 in the dark. Autofluorescence
background was monitored with cells incubated in medium without CM-
H2DCFDA, which was included in each assay. Cells were loaded with DAPI
(5 mM) and analyzed by fluorescence-activated cell sorting (LSR II, BD Biosci-
ences). Fluorescence was measured on a subset of living cells characterized
by DAPI-negative staining. At least 5000 events were counted within the
gate parameters for each sample. Background fluorescence was subtracted
from values obtained with the CM-H2DCFDA-treated samples. Results were
obtained from an average of three independent experiments for each condi-
tion, normalized with respect to measurements in control cells, and expressed
as relative ROS levels.
Immunoblotting and Immunohistochemistry
Protein extracts from tissues were prepared as described in Gerald et al. (2004).
Antibodies against IR (07-724, Upstate), phospho-IR (Tyr972) (07-838, Upstate),
Akt (9272, Cell Signaling), phospho-Akt (Ser473) (4051, Cell Signaling), FoxO1
(ab39656, Abcam),and phospho-FoxO1 (Ser256) (ab38501, Abcam) were used.
Organs were fixed in 4% PFA for 2 hr at room temperature and then embed-
ded in gelatin 15%/sucrose 7.5%. Ten micrometer sections were stained
using antibodies against insulin (A0564, Dako), glucagon (G2654, Sigma),Figure 6. Model for Regulation of Insulin Signaling Pathways by JunD
In mice, JunD regulates the expression of genes involved in the control of ROS levels. JunD is highly expressed in pancreatic b cells that are sensitive to ROS due
to low levels of antioxidant defense. Accordingly, junD deletion leads to accumulation of H2O2 in b cells. As a consequence, ROS promotes an angiogenic switch
in b islets by stabilizing HIF-1a and stimulating VEGF-A. Endothelial cells secrete large amounts of extracellular matrix (ECM) components that signal back to
endocrine cells and increase both insulin expression and Ca2+-dependent exocytosis. The large amount of insulin delivered into the systemic circulation sub-
sequently stimulates insulin signaling pathways in peripheral tissues (including liver) and partially inactivates the FoxO family of transcription factors, a pathway
that is known to control life span.
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Reactive Oxygen Species Control b Cell FunctionHIF-1a (ab1, Abcam), VEGF-A (ab2992, Abcam), fibronectin (ab3, Oncogene),
PECAM-1 (MEC 13.3, Pharmingen), SM-a-actin (A2547, Sigma), and b-Gal
(G8021, Sigma).
Mouse Islet Isolation and Ca2+ Measurements
Islets were isolated by collagenase digestion of pancreas and hand picking
(Freeman et al., 2006). Once isolated, islets were loaded for 1 hr with 1.5 mM
Fura-2 AM (Molecular Probes) and incubated at 37C in Krebs-Ringer buffer
containing 115 mM NaCl, 5 mM KCl, 24 mM NaHC03, 1 mM MgCl2, 0.5%
BSA, 2.8 mM glucose. After loading, islets were transferred onto a coverslip
and perfused continuously with 25 mM HEPES-buffered medium containing
125 mM NaCl, 5.9 mM KCl, 1.28 mM CaCl2, 1.2 mM MgCl2, 0.1% BSA and
supplemented with 2.8 or 16 mM glucose. Islets were imaged using a micro-
scope with a dual excitation system. Ca2+ signals were obtained by rationing
the fluorescence intensities detected at 510 nm after excitation at 340 nm and
380 nm. Calcium fluxes are displayed as a ratio in arbitrary units (a.u.). Back-
ground subtraction was performed by measuring fluorescence from a cell-free
region in the field of view. Experiments were performed at least three times for
each genotype.
Analysis of Gene Expression
Total RNA was isolated using TRIzol (Invitrogen) and treated with Turbo DNA-
free (Ambion). cDNAs were prepared from 1 mg of total RNA using random hex-
aprimers as templates and SuperScript III (Invitrogen). Quantitative real-time
RT-PCR was carried out on an ABI Prism 7500 system using SYBR green.
Primer sequences are listed in Table S1.
Statistical Analysis
All experiments were performed at least three times. All data are reported as
means ± SEM. Statistical analyses were performed by two-tailed Student’s
t test. Single, double, and triple asterisks indicate statistically significant differ-
ences: *p < 0.05; **p < 0.01; ***p < 0.005. All survival analyses were carried out
using the Kaplan-Meier method and the log-rank test. SPSS version 6.0 statis-
tical software was used.
Supplemental Data
Supplemental Data include two figures and one table and can be found
with this article online at http://www.cellmetabolism.org/cgi/content/full/7/2/
113/DC1/.
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